Fulcrum Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Fulcrum Therapeutics by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $416k | 89k | 4.70 |
2024-09-30 | $311k | 87k | 3.57 |
2024-06-30 | $567k | 91k | 6.20 |
2024-03-31 | $16k | 1.7k | 9.44 |
2023-12-31 | $11k | 1.7k | 6.75 |
2023-09-30 | $7.4k | 1.7k | 4.44 |
2023-06-30 | $16k | 4.8k | 3.30 |
2023-03-31 | $215k | 76k | 2.85 |
2022-12-31 | $435k | 60k | 7.28 |
2022-09-30 | $410k | 51k | 8.08 |
2022-06-30 | $233k | 48k | 4.90 |
2022-03-31 | $807k | 34k | 23.66 |
2021-12-31 | $561k | 32k | 17.69 |
2021-09-30 | $852k | 30k | 28.21 |
2021-06-30 | $236k | 23k | 10.50 |
2021-03-31 | $146k | 12k | 11.82 |
2020-12-31 | $139k | 12k | 11.72 |
2020-09-30 | $84k | 11k | 7.91 |
2020-06-30 | $233k | 13k | 18.31 |